World's Best Scientists 2026 revealed!
Cytotherapy
H-index 27

Cytotherapy

1465-3249

Published by: Elsevier

https://www.journals.elsevier.com/cytotherapy

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 84 145 337 19
Molecular Biology 139 27 59 6
Biology and Biochemistry 297 205 393 20
Medicine 1087 277 450 21

Additional Metrics

Number of Best Scientists*: 787
Documents by Best Scientists*: 1044
Top 100 Ranked Scientists*: 27
SCIMAGO H-index: 109
SCIMAGO SJR: 1.007
Impact Factor: 3.2

Overview

Top Research Topics at Cytotherapy?

Cytotherapy covers a variety of subjects, including Mesenchymal stem cell, Immunology, Cell biology, Stem cell and Cancer research. While work presented in the journal provided substantial information on Mesenchymal stem cell, it also covered topics in Cell therapy, Stromal cell, Adipose tissue and Bone marrow. The studies in Immunology featured incorporate elements of Cytotoxic T cell and Transplantation.

The Transplantation research discussed is part of studies in the fields of Internal medicine and Surgery. The research on Internal medicine tackled can also make contributions to studies in the areas of Gastroenterology and Endocrinology. It facilitates discussions on Cell biology that incorporate concepts from other fields like Cell, Cell culture and Cellular differentiation.

It connects the study in Stem cell with the closely related area of Adult stem cell.

  • Mesenchymal stem cell (30.38%)
  • Immunology (22.24%)
  • Cell biology (18.67%)

What are the most cited papers published in the journal?

  • Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement (11461 citations)
  • Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement (1519 citations)
  • Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) (1107 citations)

Research areas of the most cited articles at Cytotherapy:

The most cited articles mainly deal with areas of study such as Mesenchymal stem cell, Immunology, Stem cell, Pathology and Transplantation. Stromal cell, Cancer research, Bone marrow and Cellular differentiation are some topics wherein Mesenchymal stem cell research discussed in the journal publications has an impact. Issues in Immunology were discussed in the journal papers, taking into consideration concepts from other disciplines like Progenitor cell, Cell culture and Cell therapy.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Cancer

The previous edition focused in particular on these issues:

The journal mostly deals with topics like Mesenchymal stem cell, Cancer research, Cell biology, Cell therapy and Pathology. The studies on Mesenchymal stem cell discussed can also contribute to research in the domains of Stromal cell, Umbilical cord, Stem cell, Adipose tissue and Bone marrow. Topics in Cancer research explored in Cytotherapy were investigated in conjunction with research in T cell, Immune system and Immunotherapy.

The work tackled in Cytotherapy goes beyond the discipline of Cell biology as it also encompasses Induced pluripotent stem cell.

The most cited articles from the last journal are:

  • Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles (14 citations)
  • Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2. (11 citations)
  • Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study. (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cytotherapy (based on the number of publications) are:

  • Catherine M. Bollard (63 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • Jacques Galipeau (45 papers) published 9 papers at the last edition, 6 more than at the previous edition,
  • Massimo Dominici (45 papers) published 4 papers at the last edition, 1 more than at the previous edition,
  • Patrick J. Hanley (44 papers) published 5 papers at the last edition the same number as at the previous edition,
  • Adrian P. Gee (43 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cytotherapy (based on the number of publications) are:

  • National Institutes of Health (109 papers) published 3 papers at the last edition, 3 less than at the previous edition,
  • Boston Children's Hospital (99 papers) absent at the last edition,
  • University of Texas MD Anderson Cancer Center (77 papers) published 3 papers at the last edition,
  • University College London (72 papers) published 5 papers at the last edition, 2 less than at the previous edition,
  • Center for Cell and Gene Therapy (70 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 62.75% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 8.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 24.44% of all publications and 60.89% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles

    Mario Gimona;Maria Felice Brizzi;Andre Boon Hwa Choo;Massimo Dominici

    (2021)
    165 Citations
  • International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19.

    Verena Börger;Daniel J. Weiss;Johnathon D. Anderson;Francesc E. Borràs

    (2020)
    147 Citations
  • Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial

    Yang Liu;Yelei Guo;Zhiqiang Wu;Kaichao Feng

    (2020)
    109 Citations
  • Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.

    Sergiu Albu;Hatice Kumru;Ruth Coll;Joaquim Vives

    (2021)
    105 Citations
  • The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19.

    Peter Braendstrup;Bruce L. Levine;Marco Ruella

    (2020)
    95 Citations
  • Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes

    (2022)
    61 Citations

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to various specialized healthcare careers. For those interested in the science of human movement and physical health, pursuing an online bachelor's in kinesiology offers foundational knowledge essential for rehabilitation and sports medicine roles.

Nurses looking to advance their clinical expertise can explore fast-tracked programs such as the shortest post master's PMHNP online programs, which focus on psychiatric mental health, or the 1 year post masters FNP online option, designed to prepare Family Nurse Practitioners for expanded roles in patient care.

For those fascinated by nutrition and wellness, enrolling in the best online registered dietitian programs can be a practical pathway to becoming a licensed expert in dietetics without disrupting one’s current commitments.

These online degrees provide flexible and efficient routes to diversify skills and enhance your professional opportunities within the healthcare field.

Best Scientists Contributing to This Journal